These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 4164590

  • 1. Potentiation of the tolbutamide effect by dicoumarol.
    Kristensen M, Hansen JM.
    Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590
    [No Abstract] [Full Text] [Related]

  • 2. Potentiation of tolbutamide by dicumarol.
    Sise HS.
    Ann Intern Med; 1967 Aug; 67(2):460-1. PubMed ID: 4166650
    [No Abstract] [Full Text] [Related]

  • 3. Absence of tolbutamide effect on anticoagulant therapy.
    Poucher RL, Vecchio TJ.
    JAMA; 1966 Sep 26; 197(13):1069-70. PubMed ID: 4162027
    [No Abstract] [Full Text] [Related]

  • 4. [On a case of hypoglycemic coma in the course of tolbutamide and dicoumarol therapy].
    Fontana G, Addarii F, Peta G.
    G Clin Med; 1968 Sep 26; 49(9):849-58. PubMed ID: 4180318
    [No Abstract] [Full Text] [Related]

  • 5. Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.
    Heine P, Kewitz H, Schnapperelle U.
    Eur J Clin Pharmacol; 1974 Aug 23; 7(5):321-30. PubMed ID: 4213593
    [No Abstract] [Full Text] [Related]

  • 6. Potentiation of hypoglycemic response to intravenous tolbutamide by clofibrate.
    Ferrari C, Frezzati S, Testori GP, Bertazzoni A.
    N Engl J Med; 1976 May 20; 294(21):1184. PubMed ID: 1264124
    [No Abstract] [Full Text] [Related]

  • 7. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P, Mughini L.
    Minerva Med; 1974 Aug 29; 65(59):383-9. PubMed ID: 4213556
    [No Abstract] [Full Text] [Related]

  • 8. On the question of an interaction between sulindac and tolbutamide in the control of diabetes.
    Ryan JR, Jain AK, McMahon FG, Vargas R.
    Clin Pharmacol Ther; 1977 Feb 29; 21(2):231-3. PubMed ID: 837641
    [Abstract] [Full Text] [Related]

  • 9. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A, Catellier C.
    Union Med Can; 1974 Mar 29; 103(3):413-7. PubMed ID: 4820869
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of propranolol on the hypoglycemic action of insulin and tolbutamide in diabetic patients].
    Kowalski S, Wolański A.
    Pol Arch Med Wewn; 1969 Mar 29; 42(1):55-61. PubMed ID: 5767511
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of tolbutamide treatment on serum insulin response measured by 3 methods].
    Aburaya K.
    Nihon Naibunpi Gakkai Zasshi; 1971 Mar 20; 46(12):1206-25. PubMed ID: 5102334
    [No Abstract] [Full Text] [Related]

  • 13. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
    Melander A, Sartor G, Wåhlin E, Scherstén B, Bitzén PO.
    Br Med J; 1978 Jan 21; 1(6106):142-4. PubMed ID: 620227
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of interaction of tolbutamide and phenylbutazone in diabetic patients.
    Ober KF.
    Eur J Clin Pharmacol; 1974 Jul 26; 7(4):291-4. PubMed ID: 4853129
    [No Abstract] [Full Text] [Related]

  • 15. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J, Beyer J, Nest E, Fröhlich A, Althoff PH, Schöffling K.
    Arzneimittelforschung; 1974 Aug 26; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract] [Full Text] [Related]

  • 16. [Fluprednisolone, a corticosteroid of slight diabetogenic effect].
    Fiegel G, Kukwa D.
    Arzneimittelforschung; 1970 Jun 26; 20(6):864-5. PubMed ID: 5468909
    [No Abstract] [Full Text] [Related]

  • 17. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK.
    Geriatrics; 1968 Sep 26; 23(9):137-46. PubMed ID: 5673663
    [No Abstract] [Full Text] [Related]

  • 18. [Drug induced changes of the blood glucose lowering effect of oral hypoglycemic agents].
    Christensen LK, Kristensen M.
    Acta Diabetol Lat; 1969 Sep 26; 6 Suppl 1():116-36. PubMed ID: 4190079
    [No Abstract] [Full Text] [Related]

  • 19. [Influencing the effect of Dirastan (tolbutamide) simultaneous administration of chloramphenicol in patients with diabetes and bacterial urinary tract inflammation (author's transl)].
    Brunová E, Slabochová Z, Platilová H.
    Cas Lek Cesk; 1974 Jan 18; 113(3):72-5. PubMed ID: 4434411
    [No Abstract] [Full Text] [Related]

  • 20. [Glycemia and plasma insulin under the influence of tolbutamide and HB 419 in normal and diabetic persons].
    Quabbe HJ, Kliems G.
    Journ Annu Diabetol Hotel Dieu; 1969 Jan 18; 10():301-9. PubMed ID: 5376989
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.